Back to Financial results
ARVIND REMEDIES LIMITED
UNAUDITED FINANCIAL RESULTS
FOR THE  NINE MONTHS ENDED DECEMBER 31, 2008
   
  (Rupees in Lakhs.)
Particulars Three months ended 31.12.2008 Three months ended 31.12.2007 Corresponding  Nine Months ended 31.12.2008 Corresponding Months ended 31.12.2007 Year ended 31.3.2008
  Unaudited Unaudited Unaudited Unaudited Audited
1. (a) Net Sales 5491.62 4372.73 15896.55 12760.52 17567.15
    (b) Other Operating Income 0.28               2.13 2.09                  5.72 4.44
Total Operating Income 5491.90 4374.86 15898.64 12766.24 17571.59
           
2. Expenditure          
a) (Increase)/Decrease in stock 180.92 (82.06) 50.16 (168.82) (435.01)
b)  Consumption of Materials 4407.65 3707.16 13531.33 10910.44 15283.14
c)  Purchase of Traded Goods 74.11 0.00 106.18 30.69 30.69
d)  Employee Cost 113.63 92.31 323.74 286.41 441.04
e)  Depreciation 51.52 44.93 147.47 132.92 179.71
f)  Other expenditure 214.40 252.94 455.04 502.35 649.87
g) Total (a) to (f) 5042.23 4015.28 14613.92 11693.99 16149.44
           
3. Profit from Operation before other Income 449.67 359.58 1284.72 1072.25 1422.15
Interest & Exceptional items (1-2)          
4. Other Income 4.87                  -   10.20 5.32 15.22
           
5.Profit  before interst & Exceptional items (3+4) 454.54 359.58 1294.92 1077.57 1437.37
6. Interest 211.40 176.81 626.49 504.93 748.02
7. Profit after interst but before Exceptional items(5-6)                243.14            182.77         668.43               572.64          689.35
8. Execptional Items          
9. Profit from Ordinary activities before Tax (8-9) 243.14 182.77 668.43 572.64 689.35
10. Provision for Taxation          
       Income Tax(Including Fringe Benefit Tax) 50.00 40.00 90.00 80.00 147.23
        Earlier Years                       -                    -                  -                        -                  -  
       Deferred Tax 1.28              (3.50)            7.70                (26.98) 29.11
       Wealth Tax                       -                    -                  -                        -   0.33
11. Profit from Ordinary activities after Tax 191.86 146.27 570.73 519.62 512.68
12.Extraordinary Items (net of tax expense)                       -                    -                  -                        -                  -  
13.Net Profit for the Period 191.86 146.27 570.73 519.62 512.68
14.Paid-up Equity Share Capital 2600.50 2600.50 2600.50 2600.50 2600.50
 (face value Re.1/- per Share)          
15.Reserves excluding Revaluation Reserve                       -                    -                  -                        -   1881.86
Basic and Diluted Earnings Per Share before and after extraordinary Items (Rs.) 0.07 0.06 0.22 0.20 0.20
Public Shareholding          
Number of shares 194205340 194205340 194205340 194205340 194205340
Percentage of Shareholding 74.68% 74.68% 74.68% 74.68% 74.68%
Notes :        
1. The Company Operates only in one business segment namely formulaions.  
2.Previous period's figures have been regrouped/ rearranged wherever necessary to confirm to the current period's classification.
3. Provision for taxation for the Nine months ended December 31, 2008 has been made on an estmate basis.  The actual tax   
    liability will be determined on the basis of the taxable income of the Company for the year from April 1, 2008 to March 31,2009  
4. The above results were reviewd by the audit committee and taken on record of the meeting of the Board of Directors held on February 27, 2008
5. During the quarter 15 investor compliants were received and disposed off.  There were no investor compliants pending for redressal as at the commencement and end of the quarter
   
   
Chennai - 600 084 For ARVIND REMEDIES LTD
Date:  February 27, 2009  
  DR.B.Arvind Shah  
      CEO & Managing Director  
  Back to Financial results